Chronic hepatitis E in liver transplant recipients: A significant clinical problem?

Minerva Gastroenterologica e Dietologica

Volumn 56, Issue 2, 2010, Pages 121-128

  Pischke, S ^a   Wedemeyer, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Hepatitis E virus; Liver disease; Liver transplantation

Indexed keywords

AMINOTRANSFERASE; HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; VIRUS RNA;

AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; BLOOD ANALYSIS; CHRONIC HEPATITIS; DISEASE COURSE; DISEASE TRANSMISSION; FECES ANALYSIS; GENOTYPE; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; LIVER GRAFT; NONHUMAN; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; VACCINATION;

ANIMALS; GERMANY; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MASS SCREENING; PROGNOSIS; RISK FACTORS; WORLD HEALTH; ZOONOSES;

EID: 77954693050     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008;48:494-503.
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
3. Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003;9:448-54. (Pubitemid 37070411)
4. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, Rech H et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008;80:289-93.
5. Buti M, Plans P, Dominguez A, Jardi R, Rodriguez Frias F, Esteban R, Salleras L et al. Prevalence of hepatitis E virus infection in children in the northeast of Spain. Clin Vaccine Immunol 2008;15:732-4. (Pubitemid 351967042)
6. Buti M, Dominguez A, Plans P, Jardi R, Schaper M, Espunes J, Cardenosa N et al. Community-based sero-epidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006;13:1328-32. (Pubitemid 46086898)
7. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol Infect 2008;136:567-76. (Pubitemid 351344530)
8. Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026-31.
9. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A et al. Phylogenetic and Case-Control Study on Hepatitis E Virus Infection in Germany. J Infect Dis 2008; 198:1732-41.
10. Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO et al. Taxonomy of the caliciviruses. J Infect Dis 2000;181 Suppl 2:S322-330.
11. Pringle CR. Virus taxonomy at the XIth International Congress of Virology, Sydney, Australia, 1999. Arch Virol 1999;144:2065-70.
12. Meng J, Cong M, Dai X, Pillot J, Purdy MA, Fields HA, Khudyakov YE. Primary structure of open reading frame 2 and 3 of the hepatitis E virus isolated from Morocco. J Med Virol 1999;57:126-33. (Pubitemid 29022503)
13. Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, Fan J et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009;81:1371-9.
14. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16:5-36.
15. Buti M, Clemente-Casares P, Jardi R, Formiga-Cruz M, Schaper M, Valdes A et al. Sporadic cases of acute autochthonous hepatitis E in Spain. J Hepatol 2004;41:126-31. (Pubitemid 39005163)
16. Goens SD, Perdue ML. Hepatitis E viruses in humans and animals. Anim Health Res Rev 2004;5:145-56.
17. Meng XJ. Recent advances in Hepatitis E Virus. J Viral Hepat 2009 Dec [Epub ahead of print].
18. Kaci S, Nockler K, Johne R. Detection of hepatitis E virus in archived German wild boar serum samples. Vet Microbiol 2008;128:380-5.
19. Said B, Ijaz S, Kafatos G, Booth L, Thomas HL, Walsh A, Ramsay M et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009;15:1738-44.
20. Johne R, Plenge-Bonig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol;91:750-8.
21. Easterbrook JD, Kaplan JB, Vanasco NB, Reeves WK, Purcell RH, Kosoy MY et al. A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect 2007;135:1192-9.
22. Tei S, Kitajima N, Ohara S, Inoue Y, Miki M, Yamatani T, Yamabe H et al. Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J Med Virol 2004;74:67-70. (Pubitemid 38988861)
23. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371-3. (Pubitemid 36945060)
24. Tomiyama D, Inoue E, Osawa Y, Okazaki K. Serological evidence of infection with hepatitis E virus among wild Yezo-deer, Cervus nippon yesoensis, in Hokkaido, Japan. J Viral Hepat 2009;16:524-8.
25. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, Schlue J et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl;16:74-82.
26. Chang Y, Wang L, Geng J, Zhu Y, Fu H, Ren F, Li L et al. Zoonotic risk of hepatitis E virus (HEV): A study of HEV infection in animals and humans in suburbs of Beijing. Hepatol Res 2009;39:1153-8.
27. Geng Y, Wang C, Zhao C, Yu X, Harrison TJ, Tian K et al. Serological Prevalence of Hepatitis E Virus in Domestic Animals and Diversity of Genotype 4 Hepatitis E Virus in China. Vector Borne Zoonotic Dis 2009 Dec [Epub ahead of print].
28. Stoszek SK, Engle RE, Abdel-Hamid M, Mikhail N, Abdel-Aziz F, Medhat A et al. Hepatitis E antibody sero-conversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg 2006;100:89-94. (Pubitemid 43024763)
29. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002;40:4576-80. (Pubitemid 35434950)
30. Zaki Mel S, Foud MF, Mohamed AF. Value of hepatitis E virus detection by cell culture compared with nested PCR and serological studies by IgM and IgG. FEMS Immunol Med Microbiol 2009;56:73-9.
31. Robertson BH, Bradley DW. Enterically transmitted hepatitis. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections 1995;7th edition:361-373.
32. Bhatia V, Singhal A, Panda SK, Acharya SK. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008;48:1577-85.
33. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008;28:1190-9.
34. Peron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007;14:298-303. (Pubitemid 46587857)
35. Meng XJ. Hepatitis E virus: Animal reservoirs and zoonotic risk. Vet Microbiol 2009.
36. Arankalle VA, Chobe LP. Hepatitis E virus: can it be transmitted parenterally? J Viral Hepat 1999;6:161-4.
37. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sang 2000;79:72-4.
38. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368-75.
39. Mansuy JM, Huynh A, Abravanel F, Recher C, Peron JM, Izopet J. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009;48:373-4.
40. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006;16:79-83.
41. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007;13:648-9.
42. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008;358:811-7. (Pubitemid 351281642)
43. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;358:859-60. (Pubitemid 351281667)
44. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008;14:547-53. (Pubitemid 351524412)
45. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010;89:353-60.
46. Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009;16:895-6.
47. Pischke S, Ho H, Urbanek F, Meyer-Olsen D, Suneetha PV, Manns MP et al. Hepatitis E in HIV-positive patients in a low-endemic country. J Viral Hepat 2009 [Epub ahead of print).
48. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009;361:1025-7.
49. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009;15:1225-8.
50. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I et al. Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation. Clin Infect Dis 2010;50:e30-3.
51. Haagsma E, Riezebos-Brilman A, Van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; [Epub ahead of print].
52. Zhang J, Liu CB, Li RC, Li YM, Zheng YJ, Li YP, Luo D, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009;27:1869-1874.
53. Shrestha MP, Scott RM, Joshi DM, Mammen MP, Jr., Thapa GB, Thapa N, Myint KS, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903.
54. Clinical Trials.gov. Homepage [Internet]. Available from www.clinicaltrials.gov [cited 2010, Apr 1].
55. Colson P, Dhiver C, Gerolami R. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Mi-crobiol Infect 2008;14:1176-80.
56. Renou C, Lafeuillade A, Pavio N, Nicand E. Response to Madejon et al. are HIV-infected patients at risk of HEV infection? J Viral Hepat 2009 Sep 25. [Epub ahead of print].
57. le Coutre P, Meisel H, Hofmann J, Rocken C, Vuong GL, Neuburger S et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009;58:699-702.